#ISC24
Privacy Policy
Late-Breaking Science
Daily Coverage
Industry Highlights
Photo Gallery
Program
Home
Late-Breaking Science announced for ISC 2024
See the impressive lineup of Late-Breaking Science on tap for presentation in Phoenix.
ISC24
10 Late-Breaking Science presentations highlight Closing Main Event
ISC24
TREND, SPAN, RODIN and GOLDEN BRIDGE-II results revealed
ISC24
ZODIAC, RESILIENT-Extend and MOST Late-Breaking Science presented
Daily Coverage
Final Late-Breaking Science announced for ISC 2024
Late-Breaking Science
2023 Late-Breaking Science: BEST-II, CATIS-2, ANGEL-ASPECT, SELECT 2, ARAMIS, RESCUE BT2 and CMOSS
Late-Breaking Science
2023 Late Breaking Science: Improving stroke thrombolysis, comparing tenecteplase and alteplase, and treating cognitive decline after lacunar stroke
Sponsored
Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis and Management
The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010. Major advances in the prevention, diagnosis, and management of these infections have occurred since then, necessitating a scientific statement update.
Late-Breaking Science
2023 Late-Breaking Science: SPAN results, monitoring ischemic stroke in small- and large-vessel disease and positive neuroprotective effects from aptamer
ISC23
Stroke
simultaneous publications from ISC 2023
Seven journal articles are presented at #ISC23.
Daily Coverage
Schedule of Main Events
Each day of the #ISC23 conference features a Main Event, featuring named lectures and late-breaking science.
Home
Late-Breaking Science for #ISC23
14 late-breaking presentations have been selected for the Main Events of #ISC23.
Late-Breaking Science
Trials’ results shed light on new technology for preventing stroke, best practices and devices for LVO retrieval, the effectiveness of antiplatelet therapy with the addition of cilostazol and mechanical thrombectomy in pediatric patients with LVO
Late-Breaking Science
Trials’ results highlight the cost-effectiveness of mobile stroke units and point to advancements in treatment approaches for patients with LVO, cerebral venous thrombosis and cerebral arteriovenous malformation
Daily Coverage
Endovascular therapy, tirofiban for LVO and periodontal care highlight late-breaking science
Investigators share their late-breaking science findings during the ISC 2022 Opening Session.
Late-Breaking Science
Main Events to present late-breaking science
The latest stroke science research will be presented in New Orleans.
ISC21
Late-Breaking Science: New data in clot removal, stroke patients with COVID-19
ISC21
Roos: MR CLEAN-NO IV results
ISC21
Nogueira: SHRINE results
ISC21
Late-Breaking Science: Trials’ results point to advancements in treatment approaches for patients with ischemic stroke
ISC21
ANGIO-CAT Late-Breaking Science results
ISC21
Late-Breaking Science: Sending patients from ambulance directly to angio suite improves outcomes
ISC21
ISC 21 honors awardees
ISC21
Meet the Trialist
ISC21
How to navigate posters at #ISC21
ISC21
#ISC21 to deliver powerful Late-Breaking Science
ISC21
ISC 2022 award nominations